GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human transthyretin in complex with resveratrol

Analyse Crystal structure of human transthyretin in complex with resveratrol in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1DVS
Type
protein
Length
229 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
STL
Pockets
2 · best druggability 0.31

Structure

x-ray diffraction · 2 distinct chains · 5% helix, 52% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATransthyretinprotein1155% helix, 53% strandP02766
BTransthyretinprotein1145% helix, 52% strandP02766

Ligands and binding sites

  • STL · Resveratrol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1630.310.7514empty
2630.290.7419empty

Interfaces

1 interface between chains.

  • A–B · 926 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 1DVS · Crystal structure of human transthyretin in complex with resveratrol · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.